| Literature DB >> 36160722 |
M Seguin1, S Dringus2, S Chiomvu3, T Apollo4, E Sibanda5, V Simms6,7, S Bernays2,8, R Chikodzore9, N Redzo6, P Mlilo6, L Ndlovu6, P Nzombe6, B Ncube6, K Kranzer6,10,11, R Abbas Ferrand6,10, C D Chikwari6,10.
Abstract
SETTING: Children and adolescents with HIV encounter challenges in initiation and adherence to antiretroviral therapy (ART). A community-based support intervention of structured home visits, aimed at improving initiation, adherence and treatment, was delivered by community health workers (CHWs) to children and adolescents newly diagnosed with HIV.Entities:
Keywords: adherence; antiretroviral therapy; community health workers
Year: 2022 PMID: 36160722 PMCID: PMC9484595 DOI: 10.5588/pha.22.0009
Source DB: PubMed Journal: Public Health Action ISSN: 2220-8372
Description of visits
| Visit name | When? | Objectives |
|---|---|---|
| Initial visit | Within 1 month of diagnosis (all age groups: primary caregiver and child present) | Make initial contact with client Describe the home visit intervention Complete client details Introduce Hero Book Plan date for next visit (to occur within 2 weeks) |
| Planning for successful treatment | Within 1.5 months of HIV diagnosis (all age groups: primary caregiver and child present) | Answering questions regarding HIV arising from the clinic appointment Complete family mapping Identify strengths and resources available to the client Discussion of treatment experience to date Development of Personal Treatment Plan Continue Hero Book |
| Reviewing treatment plan and plan for disclosure | 3 months following diagnosis (young children: primary caregiver and child present; older children, just child present) | Discussion of personal treatment plan to date Discussion of side effects and management strategies Discussion of barriers to adherence and strategies to overcome these Assessment of disclosure, and plan for disclosure Linkage to locally available support services, if needed Continue Hero Book |
| Disclosing and planning for the future | 6 months following HIV diagnosis (young children: primary caregiver and child present; older children, just child present) | Discussion of personal treatment plan to date Discussion of side effects and management strategies Discussion of barriers to adherence and strategies to overcome these Follow-up on disclosure to child/others Linkage to locally available support services, if needed Preparing for hand-over and exit of programme Continue Hero Book |
| Handover and saying goodbye | 7 months following diagnosis (all age groups: primary caregiver and child present) | Complete client details Complete “Hero in Me” in Hero Book Carry out hand-over of programme to client Say goodbye |
| Additional support | Optional: only if the family requires additional support | Review personal treatment plan Follow-up on any issues that arise Review: referrals, disclosure to the child and others, support from household members Discussion around long-term maintenance of treatment Address client concerns |
| Additional support | Optional: only if the family requires additional support | Review personal treatment plan Follow-up on any issues arising Review: referrals, disclosure to the child and others, support from household members Discussion about long-term maintenance of treatment Address client concerns |
Characteristics of children living with HIV who were eligible for and who received the intervention
| Characteristic | Eligible for intervention ( | Received intervention ( | |
|---|---|---|---|
| Location | Urban | 40 (71.4) | 25 (61.0) |
| Rural | 16 (28.6) | 16 (39.0) | |
| Age, years | 2–12 | 32 (59.3) | 19 (50.0 |
| 13–18 | 22 (40.7) | 19 (50.0) | |
| Missing | 2 | 3 | |
| Sex | Female | 36 (64.3) | 24 (58.5) |
| Male | 18 (32.1) | 17 (41.5) | |
| Missing | 2 | 0 | |
| Number of visits received | 0 | 15 (26.8) | — |
| 1–4 | 14 (25.0) | 14 (34.1) | |
| 5–7 | 27 (48.2) | 27 (65.9) | |
| Registered with clinic | Yes | 43 (76.8) | 39 (95.1) |
| No | 3 (5.4) | 2 (4.9) | |
| Unknown | 10 (17.9) | 0 (0) | |
| Initiated on ART | Yes | 43 (76.8) | 39 (95.1) |
| No/unknown | 13 (23.2) | 2 (4.9) | |
| Ever had CD4 count | Yes | 24 (42.8) | 16 (39.0) |
| No | 14 (25.0) | 13 (31.7) | |
| Unknown | 28 (32.1) | 12 (29.3) | |
| Viral load test conducted[ | Yes | 32 (57.1) | 27 (65.9) |
| No | 24 (42.9) | 14 (34.2) | |
| Viral load <1000 copies/ml | Yes | 26 (81.1) | 20 (74.1) |
| No | 6 (18.8) | 7 (25.9) | |
| Not done | 24 | 14 | |
* Percentages do not always add to 100 due to missing data and rounding.
† Includes tests conducted during and after intervention.
ART = antiretroviral therapy.
Characteristics of interview participants
| Pseudonym | Type | Location, setting | Sex | Age range of interviewee | Age of child (sex) | Relationship to child | Length (min) | Number of attendees in interview |
|---|---|---|---|---|---|---|---|---|
| Hlengiwe | Adolescent | Bulawayo, home | Female | 16–19 | — | — | 42 | 1 |
| Lindiwe | Adolescent | Bulawayo, home | Female | 16–19 | — | — | 45 | 1 |
| Ayanda | Adolescent | Bulawayo, home | Male | 16–19 | — | — | 37 | 2 |
| Dumi | Adolescent | Bulawayo, home | Male | 16–19 | — | — | 31 | 1 |
| Sthabile | Adolescent | Mangwe, clinic | Female | 16–19 | — | — | 31 | 1 |
| Bandile | Caregiver | Bulawayo, clinic | Female | 21–64 | 10 (F) | Aunt | 37 | 1 |
| Thokozile | Caregiver | Bulawayo, home | Female | 21–64 | 12 (F) | Mother | 28 | 3 |
| Andile | Caregiver | Bulawayo, home | Female | 21–64 | 5 (M) | Mother | 47 | 2 |
| Gugulethu | Caregiver | Bulawayo, home | Female | 21–64 | 17 (M) | Grandmother to Ayanda | 45 | ∼3 |
| Lungile | Caregiver | Bulawayo, home | Female | 21–64 | 18 (F) | Mother to Hlengiwe | 46 | 2 |
| Thando | Caregiver | Bulawayo, home | Female | 21–64 | 8 (F) | Grandmother | 44 | ∼3 |
| Nomusa | Caregiver | Mangwe, clinic | Female | Unknown | 13 (M) | Mother | 40 | ∼3 |
| Noxolo | Caregiver | Mangwe, clinic | Female | 21–64 | 12 (M) | Sister | 31 | 2 |
| Sibongile | Caregiver | Mangwe, clinic | Female | 21–64 | 11 (F) | Grandmother | 37 | 1 |
| Sibusisiwe | Caregiver | Mangwe, clinic | Female | 21–64 | 8 (F) | Mother | 44 | 2 |
| Thandeka | Caregiver | Mangwe, clinic | Female | 21–64 | 11 (F) | Mother | 46 | 1 |
| Sandile | CHW | Bulawayo, office | Male | 21–48 | — | — | 17 | 1 |
| Buhle | CHW | Bulawayo, office | Male | 21–48 | — | — | 51 | 1 |
| Sipho | CHW | Bulawayo, office | Male | 21–48 | — | — | 41 | 1 |
| Zodwa | CHW | Bulawayo, office | Female | 21–48 | — | — | 39 | 1 |
| Ntombizodwa | CHW | Mangwe, clinic | Female | 21–48 | — | — | 53 | 1 |
| Nokuphiwa | CHW | Mangwe, clinic | Female | 21–48 | — | — | 31 | 2 |
F = female; M = male; CHW = community health worker.
FIGUREChild treatment outcomes at 12 months.